(Amounts in thousands except for per share data)
 FY 2008
    
    
    FY 2007
    
    
    FY 2006
    
    
    FY 2005
    
    
    FY 2004Net sales
    
    $
    139,639
    
    
    $
    122,963
    
    
    $
    108,413
    
    
    $
    92,965
    
    
    $
    79,606Gross profit
    
    
    86,480
    
    
    
    74,940
    
    
    
    64,684
    
    
    
    54,890
    
    
    
    45,955Operating Income
    
    
    44,350
    
    
    
    35,030
    
    
    
    26,894
    
    
    
    20,325
    
    
    
    14,956Net earnings
    
    
    30,202
    
    
    
    26,721
    
    
    
    18,333
    
    
    
    12,638
    
    
    
    9,366Basic earnings per
share
    
    $
    0.75
    
    
    $
    0.67
    
    
    $
    0.47
    
    
    $
    0.36
    
    
    $
    0.28Diluted earnings
per share
    
    $
    0.74
    
    
    $
    0.66
    
    
    $
    0.46
    
    
    $
    0.35
    
    
    $
    0.27Cash dividends
declared per share
    
    $
    0.53
    
    
    $
    0.40
    
    
    $
    0.28
    
    
    $
    0.21
    
    
    $
    0.17Book value per share
    
    $
    3.19
    
    
    $
    2.83
    
    
    $
    2.40
    
    
    $
    2.14
    
    
    $
    0.96
  FY 2008
    
    
    FY 2007
    
    
    FY 2006
    
    
    FY 2005
    
    
    FY 2004Current assets
    
    $
    99,458
    
    
    $
    93,745
    
    
    $
    80,742
    
    
    $
    69,725
    
    
    $
    35,603Current liabilities
    
    
    16,061
    
    
    
    17,067
    
    
    
    20,617
    
    
    
    19,791
    
    
    
    16,650Total assets
    
    
    146,431
    
    
    
    132,698
    
    
    
    120,528
    
    
    
    110,134
    
    
    
    68,814Long-term debt
obligations
    
    
    
    
    
    
    
    
    
    
    1,803
    
    
    
    2,684
    
    
    
    17,093Shareholders equity
    
    
    128,489
    
    
    
    112,948
    
    
    
    94,350
    
    
    
    83,333
    
    
    
    32,424




---



##### 



CORPORATE PROFILE




---



##### 



(1) If such Event of Default is a Senior Payment Default, the payment in full in cash
of all amounts due with respect to such Senior Payment Default; or (1) If such Event of Default is a Senior Payment Default, the payment in full in cash
of all amounts due with respect to such Senior Payment Default; or
 Corporate Data
    
    Meridian Bioscience, Inc. and SubsidiariesCorporate Headquarters
3471 River Hills Drive
Cincinnati, Ohio 45244
(513) 271-3700
    
    Annual Meeting
The annual meeting of the shareholders will be held on
Tuesday, January 22, 2009 at 2:00 p.m. Eastern Time at the
Holiday Inn Eastgate, 4501 Eastgate Boulevard, Cincinnati,OH 4S245.Legal Counsel
Keating Muething & Klekamp PLL
Cincinnati, Ohio
    
    Directions to the Holiday Inn Eastgate can be found on our
website: www.meridianbioscience.com.Independent Public Accountants
Grant Thornton LLP
Cincinnati, OhioTransfer Agent, Registrar and
Dividend 
Reinvestment AdministrationShareholders requiring a change
of name, address or ownership of
stock, as well as information
about shareholder records, lost
or stolen certificates, dividend
checks, dividend direct deposit,
and dividend reinvestment should
contact: Computershare Investor
Services LLC, P. O. Box 43078,
Providence, RI 02940-3078; (888)
294-8217 or (312) 601-4332:e-mail
web.queries@computershare.com;
or submit your inquiries online
through
www.computershare.com/contactus.
 
    Years Ended September 30,
    
    2008
    
    2007Quarter ended:
    
    High
    
    Low
    
    High
    
    LowDecember 31
    
    
    34.240
    
    
    
    26.500
    
    
    
    17.160
    
    
    
    13.840March 31
    
    
    36.090
    
    
    
    28.910
    
    
    
    19.950
    
    
    
    16.250June 30
    
    
    37.000
    
    
    
    25.200
    
    
    
    22.470
    
    
    
    18.390September 30
    
    
    30.500
    
    
    
    23.250
    
    
    
    31.200
    
    
    
    21.300
  Directors
    
    OfficersWilliam J. Motto
Executive Chairman of the Board
John A. Kraeutler
Chief Executive Officer
James A. Buzard, Ph.D.
Retired Executive
Vice President,
Merrell Dow
Pharmaceuticals, Inc.
Gary P. Kreider
Senior Partner,
Keating Muething &
Klekamp PLL
Robert J. Ready
Chairman of the Board
and President,
LSI Industries Inc.
David C. Phillips
Co-founder,
Cincinnati Works, Inc.
    
    William J. Motto
Executive Chairman of the Board
John A. Kraeutler
Chief Executive Officer
Richard L. Eberly
Executive Vice President,
President Meridian Life Science
Lawrence J. Baldini
Executive Vice President,
Operations and Information Systems
Grady Barnes
Vice President,
Research and Development
Antonio A. Interno
Senior Vice President,
President and
Managing Director,
Meridian Bioscience Europe
Melissa A. Lueke
Vice President,
Chief Financial Officer
Susan D. Rolih
Senior Vice President,
Regulatory Affairs and
Quality Assurance
Todd W. Motto
Vice President,
Sales and Marketing




---



##### 



PERFORMANCE GRAPH
  COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
 
 
 
 *
    
    $100 invested on 9/30/03 in stock & index-including reinvestment of dividends.